Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LEXM | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | RGS7BP | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
mRNA | GYG2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
mRNA | PANX2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
mRNA | SLIT3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | CYLD | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
mRNA | FRAT1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | SARAF | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
mRNA | LIN37 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
mRNA | PPARG | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |